Condition

Clonal Cytopenia of Undetermined Significance clinical trials and research

• 12Clinical trials
• 1Country

Newest Clonal Cytopenia of Undetermined Significance clinical trials

All recruiting trials (12)

• Clonal Hematopoiesis Effects with Chemo and Radiation in Solid Cancers

  This study tests whether clonal hematopoiesis affects outcomes for adults with solid cancers who are receiving chemotherapy or radiation.

  Recruiting Dana-Farber Cancer Institute · Boston, Massachusetts · NCT07675967

• Nicotinamide Riboside and Pterostilbene in lower risk MDS and high-risk CCUS

  This phase 2 study tests whether nicotinamide riboside plus pterostilbene can help improve blood counts in adults with lower risk MDS or high-risk CCUS who are not transfusion-dependent.

  Recruiting Phase 2 University of Colorado, Denver · Aurora, Colorado · NCT07579429

• Early treatment for high-risk Clonal Cytopenia of Undetermined Significance

  This study is testing if an early treatment with a new oral medication can help people with high-risk Clonal Cytopenia of Undetermined Significance feel better and stay healthier over three years.

  Recruiting Early Phase 1 Dana-Farber Cancer Institute · Boston, Massachusetts · NCT06802146

• Evaluating olutasidenib for patients with specific blood disorders

  This study is testing if a new drug called olutasidenib can help people with certain blood disorders feel better and improve their health.

  Recruiting at 2 sites Phase 2 M.D. Anderson Cancer Center · Miami, Florida and 1 other locations · NCT06566742

• Investigating blood cancer risks in patients with ovarian and other solid tumors

  This study is trying to see if certain cancer treatments for ovarian and other solid tumors can increase the risk of blood cancers in patients.

  Recruiting University of Washington · Seattle, Washington · NCT06295965

• Using enasidenib to treat clonal cytopenia of undetermined significance

  This study is testing if a drug called enasidenib can help people with unexplained low blood cell counts and a specific gene mutation feel better and improve their health.

  Recruiting Phase 2 Washington University School of Medicine · St Louis, Missouri · NCT06240754

• Curcumin for treating inflammation and symptoms in blood disorders

  This study is testing if a curcumin supplement can help reduce inflammation and improve symptoms in people with certain blood disorders.

  Recruiting at 2 sites Phase 2 University of Southern California · Los Angeles, California and 1 other locations · NCT06063486

• Using canakinumab to prevent cancer in patients with low blood cell counts

  This study is testing if the drug canakinumab can help prevent cancer in people with low blood cell counts and certain genetic changes.

  Recruiting at 6 sites Phase 2 Ohio State University Comprehensive Cancer Center · Miami, Florida and 5 other locations · NCT05641831

• Using statins to treat patients with clonal cytopenia and myelodysplastic syndromes

  This study is testing whether the cholesterol-lowering drugs atorvastatin and rosuvastatin can help people with clonal cytopenia and lower-risk myelodysplastic syndromes feel better and slow down their disease.

  Recruiting Phase 2 Washington University School of Medicine · St Louis, Missouri · NCT05483010

• Understanding the natural progression of blood cell disorders

  This study is trying to understand how certain blood cell disorders develop over time in adults by looking at their genes and seeing if they are linked to blood cancers and other health issues.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT04102423

• Using ascorbic acid with chemotherapy to treat relapsed or refractory lymphoma and related conditions

  This study is testing if adding vitamin C to standard chemotherapy can help people with relapsed or hard-to-treat lymphomas and related blood conditions feel better.

  Recruiting Phase 2 Mayo Clinic · Mankato, Minnesota and 3 other locations · NCT03418038

• Testing genetic markers for early detection of myeloid cancers and bone marrow failure

  This study is testing if looking for specific genetic markers in blood and tissue samples can help find myeloid cancers and bone marrow issues earlier in people who show early signs but aren't diagnosed yet.

  Recruiting at 3 sites Mayo Clinic · Scottsdale, Arizona and 2 other locations · NCT02958462

Related topics

Quick answers

How many Clonal Cytopenia of Undetermined Significance clinical trials are recruiting right now?

12, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in United States. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 7, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →